Alembic's Q1 FY 2025-26 Quarterly Results

Result Summary

• Alembic Ltd reported a 4.4% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Jun (Q1 FY 2025-26). On a year-on-year (YoY) basis, it witnessed a growth of 1.1%.
• Its expenses for the quarter were up by 24.9% QoQ and 0.5% YoY.
• The net profit decreased 14.6% QoQ and increased 10.4% YoY.
• The earnings per share (EPS) of Alembic Ltd stood at 2.4 during Q1 FY 2025-26.

Financial Statments for Q1 FY 2025-26

Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results

Company Overview

Alembic Ltd. is a well-established entity operating in the pharmaceutical industry, primarily engaged in manufacturing and marketing a diverse range of pharmaceutical products. The company's portfolio includes active pharmaceutical ingredients (APIs), generic formulations, and specialty products, catering to various therapeutic segments. Alembic Ltd. has a significant presence in both domestic and international markets, with a focus on research and development to maintain its competitive edge. While specific recent developments are not available within the provided data, the company has historically been active in expanding its manufacturing capabilities and broadening its product range to meet global standards and regulatory requirements.

Revenue

In Q1FY26, Alembic Ltd. reported a total income of ₹53.34 crores, marking a 4.4% increase from the previous quarter (Q4FY25) where the total income was ₹51.08 crores. Compared to the same quarter in the previous year (Q1FY25), total income grew by 1.1%, up from ₹52.74 crores. This steady growth in revenue reflects the company's ongoing efforts to enhance its market presence and product offerings. The gradual year-over-year increase in total income suggests a consistent performance despite the competitive pressures within the pharmaceutical industry.

Profitability

The Profit Before Tax (PBT) for Q1FY26 was ₹19.80 crores, a decrease of 18.3% from the previous quarter's ₹24.23 crores. However, this represents a slight year-over-year increase of 2.2% compared to ₹19.38 crores in Q1FY25. The Tax expense for Q1FY26 was ₹1.99 crores, which is a significant reduction of 32.3% from Q4FY25's ₹2.94 crores, and a marginal increase from ₹1.96 crores in Q1FY25. Profit After Tax (PAT) stood at ₹61.65 crores in Q1FY26, down by 14.6% from ₹72.15 crores in the prior quarter, but up by 10.4% from ₹55.82 crores in Q1FY25. Earnings Per Share (EPS) for the current quarter was ₹2.40, compared to ₹2.80 in Q4FY25, a decline of 14.3%, but a year-over-year increase of 9.1% from ₹2.20 in Q1FY25.

Operating Metrics

Total expenses for Alembic Ltd. in Q1FY26 amounted to ₹33.54 crores, which is a 24.9% increase from the previous quarter's ₹26.86 crores and a slight rise of 0.5% from ₹33.36 crores in Q1FY25. This increase in total expenses on a quarter-over-quarter basis indicates an uptick in operational or production costs. The company's ability to manage expenses while maintaining revenue growth is critical in understanding its operational efficiency. The changes in these financial metrics highlight the dynamic nature of the company's operational landscape, reflecting adjustments in response to market demands and internal strategic shifts.